| | FCM | FD | IS |
| | Responder rate | | Stockholm | 81% | 74% | 75% | | 3-Klöver | 81% | 74% | 75% | | 4-Klövern | 81% | 74% | 75% | | JÖK | 81% | 74% | 75% | | Average of selected regions | 81% | 74% | 75% | | Iron dose | | Stockholm | 1,443 | 1,356 | 1,365 | | 3-Klöver | 1,446 | 1,358 | 1,368 | | 4-Klövern | 1,443 | 1,357 | 1,365 | | JÖK | 1,441 | 1,351 | 1,360 | | Average of selected regions | 1,438 | 1,348 | 1,358 | | Number of infusions | | Stockholm | 1.7 | 1.5 | 7.3 | | 3-Klöver | 1.7 | 1.5 | 7.3 | | 4-Klövern | 1.7 | 1.5 | 7.3 | | JÖK | 1.7 | 1.5 | 7.3 | | Average of selected regions | 1.7 | 1.5 | 7.3 | | Cost of treatment (SEK) | | Stockholm | SEK 25,335 | SEK 25,618 | SEK 129,942 | | 3-Klöver | SEK 25,461 | SEK 25,701 | SEK 130,204 | | 4-Klövern | SEK 25,317 | SEK 25,645 | SEK 129,935 | | JÖK | SEK 25,365 | SEK 25,478 | SEK 129,543 | | Average of selected regions | SEK 25,274 | SEK 25,436 | SEK 129,285 | | ICER | | (FCM vs. FD) | (FCM vs. IS) | | Stockholm | | FCM more effective and less costly per responder than both FD and IS | | 3-Klöver | | | 4-Klövern | | | JÖK | | | Average of selected regions | |
|
|
